Content uploaded by Francis Beauvais
Author content
All content in this area was uploaded by Francis Beauvais on Jul 01, 2015
Content may be subject to copyright.
U68:ZSKIN405XA BAHR
Original Research Article
Skin Pharmacol Appl Skin Physiol 1998;11:111–116
Effect of Avène Spring Water on the
Activation of Rat Mast Cell by
Substance P or Antigen
F. Joly
a
M. Charveron
b
M.F. Ariès
b
J. Bidault
c
L. Kahhak
a
F. Beauvais
a
Y. Gall
b
a
SEPhRA (Société d’Etudes en
Pharmacologie: Recherche,
Applications), Paris;
b
Institut de Recherche
Pierre-Fabre, Faculté de Médecine
de Rangueil, Toulouse, and
c
CNRS URA 1159,
Les Plessis Robinson, France
OOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOO
Key Words
Peritoneal mast cell
Avène spring water
Substance P
Antigen
Histamine
Prostaglandin D
2
OOOOOO OOOOO OOOOOO OOOOO OOOOOOOOOO OOOOOOOOOOOOOOO OOOOOOOOOOOOOOO OOOOOOOOOOOOOOO O
Abstract
The biological activity of Avène water from two different
springs (‘Sainte Odile’ and ‘Val d’Orb’) was studied in vitro on
rat peritoneal mast cell activation. A dilution-dependent inhi-
bition of both histamine and prostaglandin D
2
antigen-
induced release was observed when cells were preincubated
with both Avène spring waters. They also inhibited histamine
release triggered by substance P. The ability of Avène water to
inhibit mast cell activation in vitro may be related with its
antiallergic and anti-inflammatory properties and its use in
hydrotherapy.
OOOOOOOOOO OOOOO OO
Introduction
Avène spring water, known for its thera-
peutic properties in dermato-allergology, has
long been used to treat a variety of skin dis-
eases including atopic dermatitis, psoriasis,
eczema and urticaria. In vitro, Avène water
inhibits human basophil and mast cell aller-
gen-induced activation [1, 2]. Recently, it
was shown that incubation of cultured hu-
man skin fibroblasts with Avène water in-
creased the fluidity of the plasma membrane
suggesting that its primary impact is at this
level [3].
Mast cells play an important role in the
pathophysiological changes observed in cuta-
neous allergic and inflammatory reactions.
They release preformed mediators such as his-
tamine, hydrolytic enzymes and synthesize,
after antigenic challenge, the newly formed
mediator derived from membrane phospho-
lipids, prostaglandin D
2
(PGD
2
) [4, 5]. Fur-
thermore, recent studies indicate that the ner-
vous system may also influence cutaneous
Received: July 18, 1997
Accepted: Dec. 4, 1997
ABC
Fax + 41 61 306 12 34
E-Mail karger@karger.ch
www.karger.com
© 1998 S. Karger AG, Basel
1422–2868/98/0112–0111$15.00/0
This article is also accessible online at:
http://BioMedNet.com/karger
F. Joly
SEPhRA (Société d’Etudes en Pharmacologie: Recherche, Applications)
41, avenue du Général Sarrail
F–75016 Paris (France)
Tel. +33 01 46 32 70 47, Fax +33 01 46 31 02 77
Downloaded by:
Universite Rene Descartes
198.143.43.65 - 7/1/2015 9:07:55 PM
U68:ZSKIN405XA BAHR
112
Skin Pharmacol Appl Skin Physiol
1998;11:111–116
Joly/Charveron/Ariès/Bidault/Kahhak/
Beauvais/Gall
Table 1.
Composition of the two Avène waters
tested
Val d’Orb Sainte Odile
pH 7.7 7.8
Resistivity ø/cm 2,915 2,353
Silica mg/l 12.1 14.0
Ca
2+
mg/l 59.0 42.7
Mg
2+
mg/l 26.0 21.2
Na
+
mg/l 4.6 4.8
K+ mg/l 0.8 0.8
HCO
–
3
mg/l 281 227
Cl
–
mg/l 4.2 5.4
SO
4
2–
mg/l 25.3 13.1
NO
3
2–
mg/l 1.0 1.4
NO
–
2
mg/l ! 0.02 ! 0.01
PO
4
3–
mg/l ! 0.05 0.3
F
–
mg/l ! 0.1 0.1
Br
–
mg/l ! 0.1 0.3
Arsenic Ìg/l 8 10
Bore Ìg/l 38 220
Cadmium Ìg/l ! 12
Chrome Ìg/l ! 5 ! 2
Copper Ìg/l ! 20 ! 5
Lead Ìg/l ! 5 ! 5
Iron Ìg/l 70 ! 5
Lithium Ìg/l ! 20 ! 0.1
Manganese Ìg/l ! 5 ! 2
Zinc Ìg/l ! 20 45
Strontium Ìg/l 110 100
inflammatory events through the activation
of immune cells by substance P, a neurotrans-
mitter [6, 7]. Substance P is a peptide which is
released by skin C fibers which are in the
immediate vicinity of mast cells. It can bind
to and activate mast cells of the serosal type
resulting in histamine release [5, 8].
The aim of the present study was to inves-
tigate the effect of Avène spring water on sub-
stance P- and antigen-induced degranulation
of PGD
2
release in rat peritoneal mast cells
which present the same functional character-
istics as human cutaneous mast cells.
Materials and Methods
Reagents
Substance P (Neosystem, Strasbourg, France),
HEPES, bovine serum albumin (BSA), mouse mono-
clonal IgE anti-dinitrophenyl (DNP), p-nitrophenyl-N-
acetyl-ß-D-glucosaminide, metrizamide (Sigma Chem-
ical Co., St. Louis, Mo., USA). DNP coupled to BSA
antigen was prepared according to Eisen [9] and stored
at –20
°
C.
Isolation and Purification of Rat Peritoneal Mast
Cells
Mast cells from male Wistar rats (200–300 g; Iffa-
Credo, L’Arbresle, France) were obtained following an
intraperitoneal injection of 15 ml of Tyrode’s buffer
(NaCl 137 mM, KCl 2.7 mM, glucose 5.6 mM,
NaH
2
PO
4
0.4 mM, NaHCO
3
10 mM, HEPES 4.2 mM,
BSA 0.25%, pH 7.4). After injection, the peritoneal cav-
ity was massaged for 2–3 min and the fluid collected.
The cell suspension was centrifuged (400 g, 5 min, 4
°
C)
and the pellet was resuspended in 2 ml of this buffer.
Mast cells were stained using toluidine blue solution
and counted. The number of peritoneal cells per rat var-
ied from 1.2 ! 10
7
to 1.7 ! 10
7
. Mast cells were puri-
fied on a metrizamide layer (22.5%) and then centri-
fuged (400 g, 20 min, 20
°
C). Cells at the interface were
excluded and the pellet, which contained mast cells, was
resuspended in Tyrode’s buffer. Prior to stimulation
with substance P, cells were washed by centrifugation
and resuspended in Tyrode’s buffer supplemented with
CaCl
2
0.3 mM and MgCl
2
0.5 mM. Before antigenic
stimulation, cells were resuspended in Tyrode’s buffer
containing CaCl
2
1.3 mM and MgCl
2
0.5 mM.
Avène Water
Avène waters from two different springs, ‘Sainte
Odile’ and ‘Val d’Orb’, were tested. The composition
of both Avène waters is presented in table 1. They were
supplied in glass bottles (Pierre Fabre Laboratory) and
stored at 4
°
C. Avène water was made isotonic prior to
use by dilution (9:1, v/v) in tenfold concentrated wash-
ing Tyrode. This solution was then diluted 1/2, 1/4 and
1/10 in Tyrode’s.
Downloaded by:
Universite Rene Descartes
198.143.43.65 - 7/1/2015 9:07:55 PM
U68:ZSKIN405XA BAHR
Inhibition of Mast Cell Activation by
Avène Water
Skin Pharmacol Appl Skin Physiol
1998;11:111–116
113
Mast Cell Activation and Mediator Release
Substance P stimulation: Before activation, cells
were preincubated with Avène water (stock solution or
dilutions) for 30 min at 37
°
C. Cell suspensions were
then incubated with substance P (30 ÌM) for 5 min.
Antigenic stimulation: Cells were suspended in
Ca
2+
/Mg
2+
Tyrode’s buffer and sensitized with mono-
clonal IgE anti-DNP (1Ìg/ml) for 90 min, washed by
centrifugation (300 g, 5 min, 20
°
C), and finally resus-
pended in the control Tyrode’s buffer, Avène water
or its dilutions. Cells were stimulated with DNP-BSA
(40 ng/ml) for 10 min.
The stimulations were stopped on ice and superna-
tants and pellets were obtained by centrifugation at
4
°
C. Histamine content in supernatants and sonicated
cell pellets was assessed by ELISA (Bioadvance,
France). PGD
2
released in supernatants was measured
by radioimmunoassay (Amersham, France). ß-Hexo-
saminidase (ß-hex) activity (an index of degranulation)
in supernatants and sonicated cell pellets was quanti-
fied by the hydrolysis of p-nitrophenyl-N-acetyl-ß-D-
glucosaminide as previously described [10].
Statistical Analysis
Released histamine is expressed as a percentage of
total histamine content. Spontaneous histamine re-
lease was subtracted from all values to give the net
release percentage. The net percentage of ß-hex release
was calculated using the following formula: [(S – Sc) !
100]/[(S + P) – Sc], where S is the ß-hex activity in the
supernatant of antigen-challenged cells, P is the activi-
ty in the pellet of challenged cells, and Sc is the activity
in the supernatant of unchallenged cells. The Student’s
t test was used for statistical evaluation. p values ! 5%
were considered as significant.
Results
We compared Avène waters from the
springs, ‘Sainte Odile’ and ‘Val d’Orb’, com-
paratively with a distilled water control for
their effects on mast cell degranulation, mea-
sured as histamine and ß-hex release induced
by substance P or antigen. The viability of the
cell suspensions used in all experiments in the
presence of Avène water was verified by try-
pan blue exclusion (1 95%). In addition, spon-
taneous histamine or ß-hex release (! 6%)
were not increased by the treatment with
Avène water suggesting that the cell viability
was not affected.
Incubation of mast cells with Avène water
before peptidergic or antigenic stimulation in-
duced a statistically significant and dilution-
dependent inhibition of ß-hex and histamine
release with respect to distilled water without
significant difference between Sainte Odile
and Val d’Orb spring water (fig. 1, 2). Inhibi-
tions were 35 B 4% and 40 B 4% with undi-
luted Sainte Odile and Val d’Orb spring wa-
ter, respectively. ß-hex, contained in mast cell
secretory granules, was released in a quantita-
tive relation to histamine after the stimula-
tion with antigen or substance P. Interesting-
ly, the observed inhibition of enzyme release
was related to the reduction of histamine lib-
eration (33 B 4% and 38 B 1% for Sainte
Odile and Val d’Orb, respectively).
In contrast to peptidergic activation, anti-
genic stimulation of rat mast cells resulted in
the release of the newly formed mediator
PGD
2
, derived from membrane phospholip-
ids. Pretreatment of mast cells with Avène
water reduced release of this mediator from
146 B 6 pg/1 ! 10
6
cells to 69 B 5 pg and 104
B 3 pg/1 ! 10
6
cells for Sainte Odile and Val
d’Orb spring water, respectively (fig. 3).
Discussion
The usefulness of Avène spring water in
the treatment of skin diseases, particularly
atopic dermatitis, urticaria and psoriasis,
have long been recognized. Due to their re-
lease of mediators, mast cells are involved in
many different cutaneous and inflammatory
disorders [11]. We studied this spring water in
a pharmacological assay using rat serosal mast
cells as a representative model of human cuta-
neous mast cells. Both cell types can be stimu-
lated not only via the classical antigenic IgE-
Downloaded by:
Universite Rene Descartes
198.143.43.65 - 7/1/2015 9:07:55 PM
U68:ZSKIN405XA BAHR
114
Skin Pharmacol Appl Skin Physiol
1998;11:111–116
Joly/Charveron/Ariès/Bidault/Kahhak/
Beauvais/Gall
Fig. 2.
Effect of Avène spring water on histamine
release induced by antigen. Sensitized mast cells,
preincubated (30 min, 37
°
C) with Avène water for
indicated dilutions or control buffer were stimulated
with DNP-BSA (40 ng/ml, 5 min). Results are ex-
pressed in percentages of histamine release in compari-
son to the total cell histamine content and are means of
duplicate determinations. They represent the mean B
SEM of 4 experiments. * p ! 0.05.
Fig. 1.
Effect of Avène spring water on histamine
release induced by substance P. Mast cells, preincu-
bated (30 min, 37
°
C) with Avène water for indicated
dilutions or control buffer were stimulated with sub-
stance P (30 ÌM, 5 min). Results are expressed in per-
centages of histamine release in comparison to the
total cell histamine content and are means of duplicate
determinations. They represent the mean B SEM of
4 experiments. * p ! 0.05; ** p ! 0.01; *** p ! 0.001.
Downloaded by:
Universite Rene Descartes
198.143.43.65 - 7/1/2015 9:07:55 PM
U68:ZSKIN405XA BAHR
Inhibition of Mast Cell Activation by
Avène Water
Skin Pharmacol Appl Skin Physiol
1998;11:111–116
115
dependent pathway but also by the peptider-
gic pathway [5, 8].
Avène spring water was effective in inhib-
iting mast cell activation, i.e. degranulation
and PGD
2
release induced by antigen or sub-
stance P. The ability of Avène spring water to
inhibit optical basophil degranulation and
mast cell histamine release has been reported
[1, 2]. In addition to studying histamine re-
lease, we have measured PGD
2
release and
mast cell activation by peptidergic stimula-
tion. The inhibitory effect of Avène spring
water on degranulation induced by substance
P is of particular interest because the mecha-
nisms underlying the neurogenic inflamma-
tion might be implicated in numerous patho-
logical processes such as chronic idiopathic,
cholinergic, heat and cold urticaria [12]. Fur-
thermore, the cutaneous proinflammatory ef-
fects of PGD
2
are well documented [13], and
in vivo studies demonstrated the presence of
histamine and PGD
2
in the different types of
urticaria mentioned above [14, 15]. Different
steps may constitute potential sites of cell per-
turbation leading to an inhibition of the stim-
ulation: primary interaction of substance P
(positively charged) with sialic acid residues
(negatively charged) or the cell membrane,
IgE receptor-ligand bridging, Ca
2+
entry fol-
lowing activation of membrane phospholi-
pases, etc. These hypotheses are consistent
with previous studies showing that Avène wa-
ter modified changes in the hydrodynamic
properties of cell membranes leading to an
increase in fluidity [3]. Furthermore, numer-
ous pathological processes, such as atopic ec-
zema and psoriasis, are linked to membrane
fluidity abnormalities [16]. The inhibitory ef-
fect of the thermal Avène spring water on
mast cell activation provides a physiological
mechanism that could explain its therapeutic
usefulness in controlling allergic or inflamma-
tory skin diseases.
Fig. 3.
Effect of Avène spring water on PGD
2
release induced by antigen. Sensitized mast cells,
preincubated (30 min, 37
°
C) with Avène water for
indicated dilutions or control buffer were stimulated
with DNP-BSA (40 ng/ml, 5 min). Results are ex-
pressed in pg per 1 ! 10
6
cells and represent the mean
B SEM of 4 experiments. * p ! 0.05.
Downloaded by:
Universite Rene Descartes
198.143.43.65 - 7/1/2015 9:07:55 PM
U68:ZSKIN405XA BAHR
116
Skin Pharmacol Appl Skin Physiol
1998;11:111–116
Joly/Charveron/Ariès/Bidault/Kahhak/
Beauvais/Gall
OOOOOOOOOOOOOOO OOOOOOOOOOOOOOO OOOOOOOOOOOOOOO OOOOOOOOOOOOOOO OOOOOOOOOOOOOOO OOOOOOOOOOOOOOO OOOOOOOOOOOOOOO OOOOOOOOOOOOOO
References
1 Sainte-Laudy J, Sambusy JL: Inhibi-
tion of basophil degranulation by
Avène spring water. Int J Immu-
nother 1987;4:307–312.
2 Sainte-Laudy J, Gall Y, Soto P: Inhi-
bition of human basophil and rat
mast cell activation by Avène spring
water. Agents Actions 1993;38:228–
230.
3 Cézanne L, Gaboriau F, Charveron
M, Morlière P, Tocanne JF, Duber-
tret L: Effects of the Avène spring
water on the dynamics of lipids in
the membranes of cultured fibro-
blasts. Skin Pharmacol 1993;6:231–
240.
4 Christopher BR, Lowan MA, Mar-
tin KC: Human skin mast cells:
Their dispersion, purification, and
secretory characterization. J Immu-
nol 1987;138:861–867.
5 Church MK, Lowman MA, Rees
PH, Benyon RC: Mast cells, neuro-
peptides and inflammation. Agents
Actions 1989;27:8–16.
6 Matsuda H, Kawakita K, Kiso Y,
Nakano T, Kitamura Y: Substance
P induces granulocyte infiltration
through degranulation of mast cells.
J Immunol 1989;142:927–931.
7 Hagermark O, Hokfelt T, Pernow B:
Flare and itch induced by substance
P in human skin. J Invest Dermatol
1978;71:233–235.
8 Ebertz JM, Hirshman CA, Kettel-
kamp NS, Uno H, Hanifin JM: Sub-
stance P-induced histamine release
in human cutaneous mast cells. J
Invest Dermatol 1987;88:682–685.
9 Eisen H: Preparation of purified
anti-2,4-dinitrophenyl antibodies;
in Eisen HN (ed): Methods in Medi-
cal Research. Chicago, Yearbook
Medical, 1964, vol 10, p 94.
10 Schwartz LB, Austen KF, Wasser-
man SI: Immunological release of ß-
hexosaminidase and ß-glucuroni-
dase from purified rat serosal mast
cells. J Immunol 1979;123:1445–
1450.
11 Bienenstock J, Tomioka M, Stead R,
Ernst P, Jordana M, Gauldie J, Do-
lovich J, Denburg J: Mast cell in-
volvement in various inflammatory
processes. Am Rev Respir Dis 1987;
135:5–8.
12 Landry Y: Mastocytes cutanés et in-
flammation neurogène. Rev Eur
Dermat 1990;2:79–84.
13 Maurice M: The effects of PGD
2
on
the response of human skin to hista-
mine. J Invest Dermatol 1987;89:
245–248.
14 Kaplan AP, Gray L, Shaff RE, Hora-
kova Z, Beaven MA: In vivo studies
of mediator release in cold urticaria
and cholinergic urticaria. J Allergy
Clin Immunol 1975;55:458–461.
15 Heavey DJ, Kobza-Black A, Barrow
SE, Chappell CG, Greaves MW,
Dollery CT: Prostaglandin D
2
and
histamine release in cold urticaria. J
Allergy Clin Immunol 1986;78:458–
461.
16 Ferreti G, Offidani AM, Simonetti
O, Valentino M, Curatola G, Bossi
G: Changes in membrane properties
of erythrocytes and polymorphonu-
clear cells in psoriasis. Biochem
Med Metab B 1989;41:132–138.
Downloaded by:
Universite Rene Descartes
198.143.43.65 - 7/1/2015 9:07:55 PM